Detalles de la búsqueda
1.
The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology.
World J Urol;
42(1): 248, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647689
2.
Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
World J Urol;
39(7): 2483-2490, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33135127
3.
Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study.
Ann Oncol;
31(12): 1764-1772, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979512
4.
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 studyâ.
Ann Oncol;
31(12): 1755-1763, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979511
5.
Re: "Timing of radiotherapy (RT) after radical prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]", by C. C. Parker et al. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4.
Ann Oncol;
2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38834389
6.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
Ann Oncol;
30(11): 1697-1727, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740927
7.
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?
Clin Radiol;
74(4): 259-267, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739715
8.
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
World J Urol;
36(11): 1775-1781, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171454
9.
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.
World J Urol;
36(10): 1621-1627, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29721611
10.
Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature.
Prog Urol;
28(16): 875-889, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262263
11.
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol;
33(5): 561, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121006
12.
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
World J Urol;
35(6): 943-949, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27730305
13.
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
World J Urol;
34(10): 1367-72, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26897499
14.
Imaging biomarkers in prostate cancer: role of PET/CT and MRI.
Eur J Nucl Med Mol Imaging;
42(4): 644-55, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25595344
15.
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment.
Br J Cancer;
111(2): 213-9, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25003663
16.
Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study.
Ann Oncol;
25(5): 979-86, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24562445
17.
Evaluation of bronchoalveolar lavage fluid from donkeys using four different cytological stains: A pilot study.
J Equine Vet Sci;
135: 105035, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423373
18.
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center.
Ann Oncol;
24(6): 1459-66, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23508825
19.
Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.
Int J Clin Pract;
67(6): 544-51, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23409749
20.
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.
Ann Oncol;
23(4): 973-80, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21890909